Patients on dialysis die from cancer at twice the rate as those of the same age and sex in the general population, a study found.
Researchers identified demographic and socioeconomic factors associated with differences in staging of non-small cell lung cancer at initial presentation.
An analysis of published literature sought to measure the effects of social determinants of health on precision medicine for lung cancer in various racial and ethnic patient populations.
Patients with more severe findings less likely to have prolonged delays; current smokers had more delays than former smokers.
Medicaid beneficiaries had a higher risk of death than commercially-insured patients, but the risk of death decreased if Medicaid beneficiaries underwent biomarker testing.